Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000898432-19-000918
Filing Date
2019-06-19
Accepted
2019-06-19 19:01:55
Documents
1
Period of Report
2019-06-19

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 2774
  Complete submission text file 0000898432-19-000918.txt   4235
Mailing Address 500 SAGINAW DRIVE, FIRST FLOOR REDWOOD CITY CA 94063
Business Address 500 SAGINAW DRIVE, FIRST FLOOR REDWOOD CITY CA 94063 650-595-2595
Atreca, Inc. (Issuer) CIK: 0001532346 (see all company filings)

EIN.: 273723255 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 23350 SEATTLE WA 98102
Business Address 500 5TH AVE NORTH SEATTLE WA 98109 206-709-3100
Bill & Melinda Gates Foundation (Reporting) CIK: 0001663801 (see all company filings)

State of Incorp.: WA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38935 | Film No.: 19907181